Metropolis Healthcare Limited, commonly referred to as Metropolis, is a leading diagnostic service provider headquartered in India. Established in 1980, the company has grown to become a prominent player in the healthcare industry, with a strong presence across major operational regions including Mumbai, Delhi, and Bengaluru. Specialising in pathology and diagnostic services, Metropolis offers a comprehensive range of tests, including advanced molecular diagnostics and preventive health check-ups. Their commitment to quality and innovation sets them apart, as they utilise state-of-the-art technology and adhere to stringent quality standards. With over four decades of experience, Metropolis has achieved significant milestones, including numerous accreditations and a vast network of laboratories and collection centres. This positions them as a trusted name in the healthcare sector, dedicated to enhancing patient care through accurate and timely diagnostics.
How does Metropolis Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Metropolis Healthcare's score of 25 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Metropolis Healthcare reported total carbon emissions of approximately 10,000,000 kg CO2e, comprising 220,950 kg CO2e from Scope 1, 9,815,380 kg CO2e from Scope 2, and 218,000 kg CO2e from Scope 3 emissions. The following year, 2024, emissions increased slightly, with total emissions reaching about 7,000,000 kg CO2e, including 317,680 kg CO2e from Scope 1, 6,825,350 kg CO2e from Scope 2, and 44,000 kg CO2e from Scope 3. Metropolis Healthcare has not disclosed specific reduction targets or initiatives as part of their climate commitments. However, they have reported emissions intensity metrics, indicating a focus on reducing emissions relative to revenue. In 2023, the emissions intensity for Scope 1 and 2 was approximately 0.000947 kg CO2e per rupee of turnover, which improved to about 0.000648 kg CO2e per rupee in 2024. This suggests a commitment to enhancing operational efficiency and reducing carbon footprint over time.
Access structured emissions data, company-specific emission factors, and source documents
2023 | 2024 | |
---|---|---|
Scope 1 | 220,950 | 000,000 |
Scope 2 | 9,815,380 | 0,000,000 |
Scope 3 | 218,000 | 00,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Metropolis Healthcare is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.